Triazolam is a central nervous system (CNS) depressant tranquilizer in the triazolobenzodiazepine class. It possesses pharmacological properties similar to those of other benzodiazepines, but it is generally only used as a sedative to treat severe insomnia. In addition to the hypnotic properties, triazolam's amnesic, anxiolytic, sedative, anticonvulsant, and muscle relaxant properties are pronounced, as well.Due to its short half-life, triazolam is not effective for patients who experience frequent awakenings or early wakening.
This report contains market size and forecasts of Triazolam in global, including the following market information:
Global Triazolam Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Triazolam Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Triazolam companies in 2021 (%)
The global Triazolam market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.25mg/Pcs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Triazolam include Pfizer, Novartis, Sanofi, Nhwa-group, Merck, Gilead Sciences and Teva, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Triazolam manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Triazolam Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Triazolam Market Segment Percentages, by Type, 2021 (%)
0.25mg/Pcs
0.125mg/Pcs
Global Triazolam Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Triazolam Market Segment Percentages, by Application, 2021 (%)
Adults
Older Adults
Children
Global Triazolam Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Triazolam Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Triazolam revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Triazolam revenues share in global market, 2021 (%)
Key companies Triazolam sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Triazolam sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Sanofi
Nhwa-group
Merck
Gilead Sciences
Teva